Bleeding risk of surgery and its prevention in patients with inherited platelet disorders
Excessive bleeding at surgery is a feared complication in patients with inherited platelet disorders. However, very few studies have evaluated the frequency of surgical bleeding in these hemorrhagic disorders. We performed a worldwide, multicentric, retrospective study to assess the bleeding complic...
Saved in:
Published in | Haematologica (Roma) Vol. 102; no. 7; pp. 1192 - 1203 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Italy
Ferrata Storti Foundation
01.07.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0390-6078 1592-8721 1592-8721 |
DOI | 10.3324/haematol.2016.160754 |
Cover
Abstract | Excessive bleeding at surgery is a feared complication in patients with inherited platelet disorders. However, very few studies have evaluated the frequency of surgical bleeding in these hemorrhagic disorders. We performed a worldwide, multicentric, retrospective study to assess the bleeding complications of surgery, the preventive and therapeutic approaches adopted, and their efficacy in patients with inherited platelet disorders: the Surgery in Platelet disorders And Therapeutic Approach (SPATA) study. We rated the outcome of 829 surgical procedures carried out in 423 patients with well-defined forms of inherited platelet disorders: 238 inherited platelet function disorders and 185 inherited platelet number disorders. Frequency of surgical bleeding was high in patients with inherited platelet disorders (19.7%), with a significantly higher bleeding incidence in inherited platelet function disorders (24.8%) than in inherited platelet number disorders (13.4%). The frequency of bleeding varied according to the type of inherited platelet disorder, with biallelic Bernard Soulier syndrome having the highest occurrence (44.4%). Frequency of bleeding was predicted by a pre-operative World Health Organization bleeding score of 2 or higher. Some types of surgery were associated with a higher bleeding incidence, like cardiovascular and urological surgery. The use of pre-operative pro-hemostatic treatments was associated with a lower bleeding frequency in patients with inherited platelet function disorders but not in inherited platelet number disorders. Desmopressin, alone or with antifibrinolytic agents, was the preventive treatment associated with the lowest bleedings. Platelet transfusions were used more frequently in patients at higher bleeding risk. Surgical bleeding risk in inherited platelet disorders is substantial, especially in inherited platelet function disorders, and bleeding history, type of disorder, type of surgery and female sex are associated with higher bleeding frequency. Prophylactic pre-operative pro-hemostatic treatments appear to be required and are associated with a lower bleeding incidence. |
---|---|
AbstractList | Excessive bleeding at surgery is a feared complication in patients with inherited platelet disorders. However, very few studies have evaluated the frequency of surgical bleeding in these hemorrhagic disorders. We performed a worldwide, multicentric, retrospective study to assess the bleeding complications of surgery, the preventive and therapeutic approaches adopted, and their efficacy in patients with inherited platelet disorders: the Surgery in Platelet disorders And Therapeutic Approach (SPATA) study. We rated the outcome of 829 surgical procedures carried out in 423 patients with well-defined forms of inherited platelet disorders: 238 inherited platelet function disorders and 185 inherited platelet number disorders. Frequency of surgical bleeding was high in patients with inherited platelet disorders (19.7%), with a significantly higher bleeding incidence in inherited platelet function disorders (24.8%) than in inherited platelet number disorders (13.4%). The frequency of bleeding varied according to the type of inherited platelet disorder, with biallelic Bernard Soulier syndrome having the highest occurrence (44.4%). Frequency of bleeding was predicted by a pre-operative World Health Organization bleeding score of 2 or higher. Some types of surgery were associated with a higher bleeding incidence, like cardiovascular and urological surgery. The use of pre-operative pro-hemostatic treatments was associated with a lower bleeding frequency in patients with inherited platelet function disorders but not in inherited platelet number disorders. Desmopressin, alone or with antifibrinolytic agents, was the preventive treatment associated with the lowest bleedings. Platelet transfusions were used more frequently in patients at higher bleeding risk. Surgical bleeding risk in inherited platelet disorders is substantial, especially in inherited platelet function disorders, and bleeding history, type of disorder, type of surgery and female sex are associated with higher bleeding frequency. Prophylactic pre-operative pro-hemostatic treatments appear to be required and are associated with a lower bleeding incidence. Excessive bleeding at surgery is a feared complication in patients with inherited platelet disorders. However, very few studies have evaluated the frequency of surgical bleeding in these hemorrhagic disorders. We performed a worldwide, multicentric, retrospective study to assess the bleeding complications of surgery, the preventive and therapeutic approaches adopted, and their efficacy in patients with inherited platelet disorders: the Surgery in Platelet disorders And Therapeutic Approach (SPATA) study. We rated the outcome of 829 surgical procedures carried out in 423 patients with well-defined forms of inherited platelet disorders: 238 inherited platelet function disorders and 185 inherited platelet number disorders. Frequency of surgical bleeding was high in patients with inherited platelet disorders (19.7%), with a significantly higher bleeding incidence in inherited platelet function disorders (24.8%) than in inherited platelet number disorders (13.4%). The frequency of bleeding varied according to the type of inherited platelet disorder, with biallelic Bernard Soulier syndrome having the highest occurrence (44.4%). Frequency of bleeding was predicted by a pre-operative World Health Organization bleeding score of 2 or higher. Some types of surgery were associated with a higher bleeding incidence, like cardiovascular and urological surgery. The use of pre-operative pro-hemostatic treatments was associated with a lower bleeding frequency in patients with inherited platelet function disorders but not in inherited platelet number disorders. Desmopressin, alone or with antifibrinolytic agents, was the preventive treatment associated with the lowest bleedings. Platelet transfusions were used more frequently in patients at higher bleeding risk. Surgical bleeding risk in inherited platelet disorders is substantial, especially in inherited platelet function disorders, and bleeding history, type of disorder, type of surgery and female sex are associated with higher bleeding frequency. Prophylactic pre-operative pro-hemostatic treatments appear to be required and are associated with a lower bleeding incidence.Excessive bleeding at surgery is a feared complication in patients with inherited platelet disorders. However, very few studies have evaluated the frequency of surgical bleeding in these hemorrhagic disorders. We performed a worldwide, multicentric, retrospective study to assess the bleeding complications of surgery, the preventive and therapeutic approaches adopted, and their efficacy in patients with inherited platelet disorders: the Surgery in Platelet disorders And Therapeutic Approach (SPATA) study. We rated the outcome of 829 surgical procedures carried out in 423 patients with well-defined forms of inherited platelet disorders: 238 inherited platelet function disorders and 185 inherited platelet number disorders. Frequency of surgical bleeding was high in patients with inherited platelet disorders (19.7%), with a significantly higher bleeding incidence in inherited platelet function disorders (24.8%) than in inherited platelet number disorders (13.4%). The frequency of bleeding varied according to the type of inherited platelet disorder, with biallelic Bernard Soulier syndrome having the highest occurrence (44.4%). Frequency of bleeding was predicted by a pre-operative World Health Organization bleeding score of 2 or higher. Some types of surgery were associated with a higher bleeding incidence, like cardiovascular and urological surgery. The use of pre-operative pro-hemostatic treatments was associated with a lower bleeding frequency in patients with inherited platelet function disorders but not in inherited platelet number disorders. Desmopressin, alone or with antifibrinolytic agents, was the preventive treatment associated with the lowest bleedings. Platelet transfusions were used more frequently in patients at higher bleeding risk. Surgical bleeding risk in inherited platelet disorders is substantial, especially in inherited platelet function disorders, and bleeding history, type of disorder, type of surgery and female sex are associated with higher bleeding frequency. Prophylactic pre-operative pro-hemostatic treatments appear to be required and are associated with a lower bleeding incidence. |
Author | Tosetto, Alberto Orsini, Sara Santoro, Cristina Fabris, Fabrizio Nurden, Paquita Cattaneo, Marco Mumford, Andrew D. Miyazaki, Koji Noris, Patrizia Bury, Loredana Kadir, Rezan A. Falcinelli, Emanuela Flaujac, Claire Favier, Remi Henskens, Yvonne De Maistre, Emmanuel Cid, Ana Rosa Melazzini, Federica Zúñiga, Pamela Eker, Ibrahim Lambert, Michele P. Heller, Paula G. Glembotsky, Ana C. Bussel, James Podda, Gian Marco Lozano, Maria Luisa Pecci, Alessandro De Candia, Erica Schlegel, Nicole Butta, Nora C. Gresele, Paolo Fouassier, Marc Bayart, Sophie Zieger, Barbara Ozdemir, Gul Nihal Bermejo, Nuria |
AuthorAffiliation | 1 Department of Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Italy 15 Department of Hematology, Hospital San Pedro de Alcántara, Cáceres, Spain 3 Hematología Investigación, Instituto de Investigaciones Médicas Alfredo Lanari, Universidad de Buenos Aires, CONICET, Argentina 6 Unidad de Hematología, Hospital Universitario La Paz-IDIPaz, Madrid, Spain 22 Gülhane Military Medical Faculty, Pediatric Hematology Department, Ankara, Turkey 7 Unidad de Hemostasia y Trombosis, Hospital Universitario y Politecnico La Fe, Valencia, Spain 21 Cerrahpasa Medical Faculty, Pediatric Hematology Department, Istanbul, Turkey 16 Assistance Publique-Hôpitaux de Paris, Armand Trousseau Children’s Hospital, French Reference Centre for Inherited Platelet Disorders, Paris, France 10 Department of Hematology, Kitasato University School of Medicine, Sagamihara, Japan 25 1 st Division of Hematology, Department of Pediatrics, Children’s Hospital of Philadelphia, Perelman School of Medici |
AuthorAffiliation_xml | – name: 17 Hematological Laboratory, Maastricht University Medical Centre, Maastricht, The Netherlands – name: 29 Centre de Référence des Pathologies Plaquettaires (CRPP), Service d’Hématologie Biologique, CHU Robert Debré, AP-HP, Paris, France – name: 18 Department of Biology and Haematology, Centre Hospitalier Universitaire Dijon, France – name: 26 Department of Pediatrics, Division of Hematology, Weill Cornell Medicine, New York, NY, USA – name: 3 Hematología Investigación, Instituto de Investigaciones Médicas Alfredo Lanari, Universidad de Buenos Aires, CONICET, Argentina – name: 20 School of Clinical Sciences, University of Bristol, UK – name: 5 Haemophilia Centre and Haemostasis Unit, Royal Free Hospital, London, UK – name: 1 Department of Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Italy – name: 24 Centre Régional de Traitement des Hémophiles, Centre Hospitalier Universitaire de Rennes, France – name: 2 Department of Internal Medicine, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy – name: 15 Department of Hematology, Hospital San Pedro de Alcántara, Cáceres, Spain – name: 4 La Sapienza University of Rome, Italy – name: 7 Unidad de Hemostasia y Trombosis, Hospital Universitario y Politecnico La Fe, Valencia, Spain – name: 23 Reference Centre for Platelet Disorders, Bordeaux University Hospital Centre, Rythmology and Cardiac Modeling Institute (LIRYC), Xavier Arnozan Hospital, Pessac, France – name: 25 1 st Division of Hematology, Department of Pediatrics, Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PN, USA – name: 19 Hemostasis and Thrombosis Unit, Institute of Internal Medicine, Policlinico Agostino Gemelli-Università Cattolica Sacro Cuore, Rome, Italy – name: 12 Department of Hematology-Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile – name: 14 Medicina III, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Italy – name: 28 Hematology Department, S. Bortolo Hospital, Vicenza, Italy – name: 9 Consultations d’Hémostase – CRTH, CHU de Nantes, France – name: 6 Unidad de Hematología, Hospital Universitario La Paz-IDIPaz, Madrid, Spain – name: 27 Department of Pediatrics and Adolescent Medicine, University Medical Center Freiburg, Germany – name: 11 Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguery Centro Regional de Hemodonación, IMIB-Arrixaca, Universidad de Murcia, Murcia 30003 and Grupo de Investigación CB15/00055 del Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain – name: 16 Assistance Publique-Hôpitaux de Paris, Armand Trousseau Children’s Hospital, French Reference Centre for Inherited Platelet Disorders, Paris, France – name: 8 Clinica Medica 1 - Medicina Interna CLOPD, Dipartimento Assistenziale Integrato di Medicina, Azienda-Ospedale Università di Padova and Dipartimento di Medicina, Università di Padova, Italy – name: 21 Cerrahpasa Medical Faculty, Pediatric Hematology Department, Istanbul, Turkey – name: 10 Department of Hematology, Kitasato University School of Medicine, Sagamihara, Japan – name: 13 Service d’Hématologie Biologique Cochin Hospital, Paris, France – name: 22 Gülhane Military Medical Faculty, Pediatric Hematology Department, Ankara, Turkey |
Author_xml | – sequence: 1 givenname: Sara surname: Orsini fullname: Orsini, Sara – sequence: 2 givenname: Patrizia surname: Noris fullname: Noris, Patrizia – sequence: 3 givenname: Loredana surname: Bury fullname: Bury, Loredana – sequence: 4 givenname: Paula G. surname: Heller fullname: Heller, Paula G. – sequence: 5 givenname: Cristina surname: Santoro fullname: Santoro, Cristina – sequence: 6 givenname: Rezan A. surname: Kadir fullname: Kadir, Rezan A. – sequence: 7 givenname: Nora C. surname: Butta fullname: Butta, Nora C. – sequence: 8 givenname: Emanuela surname: Falcinelli fullname: Falcinelli, Emanuela – sequence: 9 givenname: Ana Rosa surname: Cid fullname: Cid, Ana Rosa – sequence: 10 givenname: Fabrizio surname: Fabris fullname: Fabris, Fabrizio – sequence: 11 givenname: Marc surname: Fouassier fullname: Fouassier, Marc – sequence: 12 givenname: Koji surname: Miyazaki fullname: Miyazaki, Koji – sequence: 13 givenname: Maria Luisa surname: Lozano fullname: Lozano, Maria Luisa – sequence: 14 givenname: Pamela surname: Zúñiga fullname: Zúñiga, Pamela – sequence: 15 givenname: Claire surname: Flaujac fullname: Flaujac, Claire – sequence: 16 givenname: Gian Marco surname: Podda fullname: Podda, Gian Marco – sequence: 17 givenname: Nuria surname: Bermejo fullname: Bermejo, Nuria – sequence: 18 givenname: Remi surname: Favier fullname: Favier, Remi – sequence: 19 givenname: Yvonne surname: Henskens fullname: Henskens, Yvonne – sequence: 20 givenname: Emmanuel surname: De Maistre fullname: De Maistre, Emmanuel – sequence: 21 givenname: Erica surname: De Candia fullname: De Candia, Erica – sequence: 22 givenname: Andrew D. surname: Mumford fullname: Mumford, Andrew D. – sequence: 23 givenname: Gul Nihal surname: Ozdemir fullname: Ozdemir, Gul Nihal – sequence: 24 givenname: Ibrahim surname: Eker fullname: Eker, Ibrahim – sequence: 25 givenname: Paquita surname: Nurden fullname: Nurden, Paquita – sequence: 26 givenname: Sophie surname: Bayart fullname: Bayart, Sophie – sequence: 27 givenname: Michele P. surname: Lambert fullname: Lambert, Michele P. – sequence: 28 givenname: James surname: Bussel fullname: Bussel, James – sequence: 29 givenname: Barbara surname: Zieger fullname: Zieger, Barbara – sequence: 30 givenname: Alberto surname: Tosetto fullname: Tosetto, Alberto – sequence: 31 givenname: Federica surname: Melazzini fullname: Melazzini, Federica – sequence: 32 givenname: Ana C. surname: Glembotsky fullname: Glembotsky, Ana C. – sequence: 33 givenname: Alessandro surname: Pecci fullname: Pecci, Alessandro – sequence: 34 givenname: Marco surname: Cattaneo fullname: Cattaneo, Marco – sequence: 35 givenname: Nicole surname: Schlegel fullname: Schlegel, Nicole – sequence: 36 givenname: Paolo surname: Gresele fullname: Gresele, Paolo |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28385783$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kkFvVCEUhYmpsdPqPzCGpZs3BR48wIWJNmqbNHGjC1eEB5cZ6pvHCExN_72M0zHWhSvCufd8Nzf3nKGTOc2A0EtKln3P-MXawsbWNC0ZocOSDkQK_gQtqNCsU5LRE7QgvSZdK6hTdFbKLSGMaC2foVOmeiWk6hfo2_sJwMd5hXMs33EKuOzyCvI9trPHsRa8zXAHc41pxnHGW1tj-xX8M9Z1E9aQYwWPt5OtMEHFPpaUPeTyHD0Ndirw4uE9R18_fvhyedXdfP50ffnupnNc8tpxApYRZ4OWlAg3jmT0wAaw2ks5UjcwEqwQY9M4VUEScMSHQJRzgRFP-nN0feD6ZG_NNseNzfcm2Wh-CymvjM01ugmMDqzXWo3OUcql5SpoIp1UXkkeqNSN9fbA2u7GDXjXNs12egR9XJnj2qzSnRFiGAgTDfD6AZDTjx2UajaxOJgmO0PaFUOVElr0XNLW-urvWX-GHG_TGt4cGlxOpWQIxsVq94doo-NkKDH7IJhjEMw-COYQhGbm_5iP_P_afgEM-7xL |
CitedBy_id | crossref_primary_10_1111_ans_18208 crossref_primary_10_7759_cureus_57345 crossref_primary_10_1055_s_0044_1782519 crossref_primary_10_1016_j_tmrv_2018_05_002 crossref_primary_10_1080_09537104_2024_2380374 crossref_primary_10_1080_09537104_2025_2470758 crossref_primary_10_1016_j_thromres_2022_11_021 crossref_primary_10_3390_jcm9020539 crossref_primary_10_3390_jcm9082508 crossref_primary_10_47717_turkjsurg_2022_4567 crossref_primary_10_3390_ijms22094330 crossref_primary_10_1055_a_1700_7036 crossref_primary_10_1111_bjh_18570 crossref_primary_10_35366_116172 crossref_primary_10_1111_ejh_14198 crossref_primary_10_1111_hae_14986 crossref_primary_10_3390_ijms22094521 crossref_primary_10_1002_rth2_12193 crossref_primary_10_1016_j_jtha_2023_07_006 crossref_primary_10_1007_s12325_020_01453_4 crossref_primary_10_1097_HS9_0000000000000601 crossref_primary_10_1186_s13023_023_02787_2 crossref_primary_10_1155_2020_2342837 crossref_primary_10_1177_1074248419838512 crossref_primary_10_1182_bloodadvances_2020004057 crossref_primary_10_1016_j_pathol_2019_10_005 crossref_primary_10_1126_scitranslmed_aay0203 crossref_primary_10_1182_blood_2020010038 crossref_primary_10_1371_journal_pone_0220625 crossref_primary_10_1002_rth2_12114 crossref_primary_10_1016_j_anrea_2018_10_003 crossref_primary_10_3390_cancers15205049 crossref_primary_10_1016_j_clineuro_2022_107181 crossref_primary_10_1016_j_blre_2020_100784 crossref_primary_10_1016_j_acvd_2018_10_004 crossref_primary_10_1055_s_0041_1728786 crossref_primary_10_1016_j_rpth_2024_102552 crossref_primary_10_1111_trf_17594 crossref_primary_10_1097_MBC_0000000000000719 crossref_primary_10_25284_2519_2078_2_107__2024_308308 crossref_primary_10_1097_EJA_0000000000001803 crossref_primary_10_1016_j_arth_2021_04_024 crossref_primary_10_17533_udea_iatreia_310 crossref_primary_10_1097_MBC_0000000000001045 crossref_primary_10_1016_j_thromres_2019_07_014 crossref_primary_10_3390_hematolrep15030041 crossref_primary_10_1186_s13054_019_2347_3 crossref_primary_10_1111_ijlh_13638 crossref_primary_10_1016_j_jpp_2018_02_003 crossref_primary_10_1111_ijlh_12814 crossref_primary_10_1016_j_rpth_2023_102305 crossref_primary_10_1080_09537104_2020_1745169 crossref_primary_10_1016_j_tracli_2018_07_003 crossref_primary_10_1007_s10815_024_03249_9 crossref_primary_10_1111_bjh_15409 crossref_primary_10_1111_hae_14643 crossref_primary_10_1111_jth_14683 crossref_primary_10_2147_JBM_S271744 crossref_primary_10_1016_j_accpm_2018_10_004 crossref_primary_10_1038_s44161_024_00421_3 crossref_primary_10_3390_jcm12196372 crossref_primary_10_1111_jocs_14354 crossref_primary_10_1177_08971900221119167 crossref_primary_10_1016_j_bja_2018_09_010 crossref_primary_10_3324_haematol_2021_278776 crossref_primary_10_1007_s40140_022_00521_5 crossref_primary_10_1016_S0049_3848_19_30368_8 crossref_primary_10_1016_j_thromres_2019_06_009 crossref_primary_10_1097_HS9_0000000000000286 crossref_primary_10_1111_ijlh_12995 crossref_primary_10_3390_jcm10030533 crossref_primary_10_1016_j_rpth_2024_102334 crossref_primary_10_1002_jbio_202300221 crossref_primary_10_1002_rth2_12374 crossref_primary_10_1055_s_0041_1726344 crossref_primary_10_1097_ACO_0000000000000999 crossref_primary_10_1097_TXD_0000000000001303 crossref_primary_10_3324_haematol_2022_280856 crossref_primary_10_7759_cureus_76233 crossref_primary_10_1080_09537104_2017_1371290 crossref_primary_10_1002_humu_23927 crossref_primary_10_1111_hae_14559 crossref_primary_10_1055_a_1515_0813 crossref_primary_10_1055_a_2462_6609 crossref_primary_10_1080_17474086_2019_1562333 crossref_primary_10_1002_pbc_29622 crossref_primary_10_1530_EOR_22_0054 crossref_primary_10_1055_a_1344_7279 crossref_primary_10_1111_jth_15263 crossref_primary_10_36290_uro_2019_041 |
ContentType | Journal Article |
Copyright | Copyright© 2017 Ferrata Storti Foundation. Copyright© 2017 Ferrata Storti Foundation 2017 |
Copyright_xml | – notice: Copyright© 2017 Ferrata Storti Foundation. – notice: Copyright© 2017 Ferrata Storti Foundation 2017 |
CorporateAuthor | European Hematology Association - Scientific Working Group (EHA-SWG) on thrombocytopenias and platelet function disorders |
CorporateAuthor_xml | – name: European Hematology Association - Scientific Working Group (EHA-SWG) on thrombocytopenias and platelet function disorders |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.3324/haematol.2016.160754 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1592-8721 |
EndPage | 1203 |
ExternalDocumentID | oai_doaj_org_article_9f23998bcc1147a48f907c78d874f179 PMC5566025 28385783 10_3324_haematol_2016_160754 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 29I 2WC 53G 5GY 5RE 5VS AAFWJ AAYXX ADBBV AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BTFSW C1A CITATION CS3 DIK E3Z EBS EJD F5P FRP GROUPED_DOAJ H13 HYE KQ8 OK1 OVT P2P RHI RNS RPM SJN TFS TR2 UDS W8F WOQ WOW CGR CUY CVF ECM EIF M~E NPM RHF SV3 7X8 5PM |
ID | FETCH-LOGICAL-c474t-40ea20caf97105cbb0bde26ea9d77b1c620fa55be26418f70ec0dff08ccf20d03 |
IEDL.DBID | DOA |
ISSN | 0390-6078 1592-8721 |
IngestDate | Wed Aug 27 01:06:05 EDT 2025 Thu Aug 21 13:52:47 EDT 2025 Thu Jul 10 22:43:57 EDT 2025 Wed Feb 19 02:43:00 EST 2025 Thu Apr 24 22:57:49 EDT 2025 Tue Jul 01 04:22:05 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
License | Copyright© 2017 Ferrata Storti Foundation. https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c474t-40ea20caf97105cbb0bde26ea9d77b1c620fa55be26418f70ec0dff08ccf20d03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/9f23998bcc1147a48f907c78d874f179 |
PMID | 28385783 |
PQID | 1885953471 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_9f23998bcc1147a48f907c78d874f179 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5566025 proquest_miscellaneous_1885953471 pubmed_primary_28385783 crossref_citationtrail_10_3324_haematol_2016_160754 crossref_primary_10_3324_haematol_2016_160754 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-07-01 |
PublicationDateYYYYMMDD | 2017-07-01 |
PublicationDate_xml | – month: 07 year: 2017 text: 2017-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Italy |
PublicationPlace_xml | – name: Italy |
PublicationTitle | Haematologica (Roma) |
PublicationTitleAlternate | Haematologica |
PublicationYear | 2017 |
Publisher | Ferrata Storti Foundation |
Publisher_xml | – name: Ferrata Storti Foundation |
References | 19657319 - Blood Coagul Fibrinolysis. 2009 Apr;20(3):215-7 23710629 - Transfusion. 2014 Feb;54(2):300-5 12411289 - Blood. 2003 Mar 15;101(6):2089-93 22775395 - Vox Sang. 2012 Nov;103(4):284-93 22583386 - J Oral Pathol Med. 2013 Feb;42(2):115-24 21113246 - Transfus Med Hemother. 2010;37(5):237-246 16307424 - Klin Padiatr. 2005 Nov-Dec;217(6):365-70 20626619 - J Thromb Haemost. 2010 Sep;8(9):2063-5 25899604 - Br J Haematol. 2015 Aug;170(4):559-63 7459811 - Cancer. 1981 Jan 1;47(1):207-14 25403439 - J Thromb Haemost. 2015 Feb;13(2):314-22 24957661 - Transfus Med. 2014 Aug;24(4):213-8 24786773 - Blood. 2014 Jun 26;123(26):4037-44 22398565 - Thromb Haemost. 2012 Jun;107(6):1188-9 26001792 - Haematologica. 2015 Aug;100(8):1038-44 12192307 - Blood Coagul Fibrinolysis. 2002 Sep;13(6):551-3 17107346 - Br J Haematol. 2006 Dec;135(5):603-33 20844233 - Blood. 2010 Dec 23;116(26):5832-7 21953125 - World J Surg. 2011 Dec;35(12):2603-10 15567653 - J Clin Anesth. 2004 Sep;16(6):458-60 23020613 - Platelets. 2012;23 (7):552-63 22510862 - Semin Thromb Hemost. 2012 Apr;38(3):292-8 19882326 - Surg Today. 2009;39(11):1002-5 21670242 - Circulation. 2011 Jun 14;123(23):2736-47 23940247 - Pediatrics. 2013 Sep;132(3):e793-5 24976115 - J Thromb Haemost. 2014 Sep;12(9):1562-9 25068867 - Blood Coagul Fibrinolysis. 2014 Dec;25(8):907-8 19631969 - Thromb Res. 2009 Nov;124(5):e13-8 27484722 - Hamostaseologie. 2016 Nov 7;36(4):265-278 10823254 - Thromb Haemost. 2000 May;83(5):644-7 26962877 - Semin Thromb Hemost. 2016 Apr;42(3):292-305 24763399 - Haematologica. 2014 Aug;99(8):1387-94 16210149 - J Heart Lung Transplant. 2005 Oct;24(10):1697-9 24739923 - J Indian Soc Pedod Prev Dent. 2014 Apr-Jun;32(2):181-4 22188821 - Int J Pediatr Otorhinolaryngol. 2012 Feb;76(2):291-4 17174124 - Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 May;103(5):626-9 |
References_xml | – reference: 26962877 - Semin Thromb Hemost. 2016 Apr;42(3):292-305 – reference: 21113246 - Transfus Med Hemother. 2010;37(5):237-246 – reference: 17174124 - Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 May;103(5):626-9 – reference: 25899604 - Br J Haematol. 2015 Aug;170(4):559-63 – reference: 22583386 - J Oral Pathol Med. 2013 Feb;42(2):115-24 – reference: 24957661 - Transfus Med. 2014 Aug;24(4):213-8 – reference: 25068867 - Blood Coagul Fibrinolysis. 2014 Dec;25(8):907-8 – reference: 10823254 - Thromb Haemost. 2000 May;83(5):644-7 – reference: 25403439 - J Thromb Haemost. 2015 Feb;13(2):314-22 – reference: 20626619 - J Thromb Haemost. 2010 Sep;8(9):2063-5 – reference: 16210149 - J Heart Lung Transplant. 2005 Oct;24(10):1697-9 – reference: 22188821 - Int J Pediatr Otorhinolaryngol. 2012 Feb;76(2):291-4 – reference: 22398565 - Thromb Haemost. 2012 Jun;107(6):1188-9 – reference: 24976115 - J Thromb Haemost. 2014 Sep;12(9):1562-9 – reference: 16307424 - Klin Padiatr. 2005 Nov-Dec;217(6):365-70 – reference: 21953125 - World J Surg. 2011 Dec;35(12):2603-10 – reference: 20844233 - Blood. 2010 Dec 23;116(26):5832-7 – reference: 17107346 - Br J Haematol. 2006 Dec;135(5):603-33 – reference: 27484722 - Hamostaseologie. 2016 Nov 7;36(4):265-278 – reference: 23710629 - Transfusion. 2014 Feb;54(2):300-5 – reference: 24739923 - J Indian Soc Pedod Prev Dent. 2014 Apr-Jun;32(2):181-4 – reference: 15567653 - J Clin Anesth. 2004 Sep;16(6):458-60 – reference: 24786773 - Blood. 2014 Jun 26;123(26):4037-44 – reference: 22775395 - Vox Sang. 2012 Nov;103(4):284-93 – reference: 22510862 - Semin Thromb Hemost. 2012 Apr;38(3):292-8 – reference: 19631969 - Thromb Res. 2009 Nov;124(5):e13-8 – reference: 21670242 - Circulation. 2011 Jun 14;123(23):2736-47 – reference: 19657319 - Blood Coagul Fibrinolysis. 2009 Apr;20(3):215-7 – reference: 12192307 - Blood Coagul Fibrinolysis. 2002 Sep;13(6):551-3 – reference: 23020613 - Platelets. 2012;23 (7):552-63 – reference: 23940247 - Pediatrics. 2013 Sep;132(3):e793-5 – reference: 19882326 - Surg Today. 2009;39(11):1002-5 – reference: 26001792 - Haematologica. 2015 Aug;100(8):1038-44 – reference: 7459811 - Cancer. 1981 Jan 1;47(1):207-14 – reference: 12411289 - Blood. 2003 Mar 15;101(6):2089-93 – reference: 24763399 - Haematologica. 2014 Aug;99(8):1387-94 |
SSID | ssj0020997 |
Score | 2.5253258 |
Snippet | Excessive bleeding at surgery is a feared complication in patients with inherited platelet disorders. However, very few studies have evaluated the frequency of... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1192 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over Blood Platelet Disorders - complications Blood Platelet Disorders - congenital Blood Platelet Disorders - diagnosis Child Child, Preschool Female Hemorrhage - epidemiology Hemorrhage - etiology Hemorrhage - prevention & control Humans Incidence Male Middle Aged Patient Outcome Assessment Postoperative Complications - epidemiology Postoperative Complications - etiology Postoperative Complications - prevention & control Premedication - methods Risk Assessment Risk Factors Surgical Procedures, Operative - adverse effects Surgical Procedures, Operative - methods Treatment Outcome Young Adult |
Title | Bleeding risk of surgery and its prevention in patients with inherited platelet disorders |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28385783 https://www.proquest.com/docview/1885953471 https://pubmed.ncbi.nlm.nih.gov/PMC5566025 https://doaj.org/article/9f23998bcc1147a48f907c78d874f179 |
Volume | 102 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_Sg3gR2_qxWiWCeFual2Q3ybEVSxHqyUI9hXzSB8_dR_f14H_vTDbv0SdCL16zWRIyk8xvMjO_EPJJeRWi56IVgXetDDK1TsXUKmeyd9H0XWHgu_reX17LbzfdzYOnvjAnbKYHnhfu1GSsvtQ-BEDuykmdwZ0LSketZAZtwtOXGbZ1pqqrhfWgJX5gwDkCKzgXzQlAD6e3DslQRww7LHq8XFGd3DNKhbv_X4Dz77zJB4bo4gV5XhEkPZtnfkiepOGIHJ8NMNqv3_QzLTmd5bL8iDy9qqHzY_LzfDUbKorZ5HTMdJoroqkbIl1uJrqubE7jQJcDrYSrE8WbWmjAOkFAp3S9AnQKwqax8nZOL8n1xdcfXy7b-q5CG6SSG3AZk-MsuGwAXnTBe-Zj4n1yJirlF6HnLLuu89AmFzorlgKLOTMdQuYsMvGKHAzjkN4Qmk0PDqKQpaIVyey40VxIr01O4BvphojtwtpQScfx7YuVBecDxWG34rAoDjuLoyHt7q_1TLrxSP9zlNmuL1JmlwZQJFsVyT6mSA35uJW4hS2GcRM3pPF-sguNJHACzHhDXs8asBsK0JmGQ080RO3pxt5c9r8My9tC490BkgbE-fZ_TP4decYRb5Q84hNysLm7T-8BLW38h7Ix_gApjRJS |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bleeding+risk+of+surgery+and+its+prevention+in+patients+with+inherited+platelet+disorders&rft.jtitle=Haematologica+%28Roma%29&rft.au=Sara+Orsini&rft.au=Patrizia+Noris&rft.au=Loredana+Bury&rft.au=Paula+G.+Heller&rft.date=2017-07-01&rft.pub=Ferrata+Storti+Foundation&rft.issn=0390-6078&rft.eissn=1592-8721&rft.volume=102&rft.issue=7&rft_id=info:doi/10.3324%2Fhaematol.2016.160754&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_9f23998bcc1147a48f907c78d874f179 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0390-6078&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0390-6078&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0390-6078&client=summon |